Concepedia

Xing‐Ping Dai

XD

Statistics

Publications

4

Citations

124

H-Index

4

Active since

2010

Affiliations

Central South University(Current)

Xiangya Hospital Central South University

Anhui Medical University

PharmacoGenetics (China)

Xing‐Ping Dai is an author at Central South University specializing in epidemiology, metabolic syndrome, and diabetes.

Top concepts

Publications per year

2010–2012

4

Publications

4

<scp><i>KCNQ1</i></scp> gene polymorphisms are associated with the therapeutic efficacy of repaglinide in <scp>C</scp>hinese <scp>T</scp>ype 2 diabetic patients

Xing‐Ping Dai, Qiong Huang, Ji‐Ye Yin et al. · Clinical and Experimental Pharmacology and Physiology · 2012 · 38 citations

, , +18

Effects of the Peroxisome Proliferator Activated Receptor‐γ Coactivator‐1α <i>(PGC‐1α) Thr394Thr</i> and <i>Gly482Ser</i> Polymorphisms on Rosiglitazone Response in Chinese Patients With Type 2 Diabetes Mellitus

Ke‐Han Zhang, Qiong Huang, Xing‐Ping Dai et al. · The Journal of Clinical Pharmacology · 2010 · 35 citations

<i>NeuroD1</i>A45T and<i>PAX4</i>R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes

Zhicheng Gong, Qiong Huang, Xing‐Ping Dai et al. · British Journal of Clinical Pharmacology · 2012 · 29 citations · Full text

Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2

Min Dong, Zhicheng Gong, Xing‐Ping Dai et al. · Clinical and Experimental Pharmacology and Physiology · 2011 · 22 citations

1–4 of 4